Envision Pharma Group | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129233	Press releases

Headlines Articles Press releases Envision Pharma Group

Home
Companies
Envision Pharma Group

PRESS RELEASE

published on 01/18/2024 at 13:00, 2 years 7 months ago

Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer
Envision Pharma Group appoints Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team. With her extensive experience in the life sciences industry, Carolyn is set to play a crucial role in securing and retaining top talent to support Envision's growth. Her strategic vision aligns seamlessly with the company's priorities, and her exceptional leadership experience will be integral to advancing Envision's strategic goals.

Envision Pharma Group Talent Acquisition Life Sciences Industry Carolyn Bartholdson Chief People Officer
PRESS RELEASE

published on 01/16/2024 at 13:00, 2 years 7 months ago

Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC)
Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) to lead the organization's IMC division of experts in medical strategy, medical communications, publications planning and delivery, and patient engagement, delivering smarter, faster outcomes for life sciences clients. With a wealth of experience in the global life sciences industry, Alice brings strategic expertise, knowledge, and insight to drive the company's vision forward and meet client needs. She joins from IPG Health, where she served as EVP, Managing Director, Client Solutions, APAC, and played a pivotal role in business growth and operational excellence. Her commitment to best practices and standards in medical communications is evident in her various leadership roles. Envision Pharma Group, founded in 2001, is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies. Learn more at www.envisionpharmagroup.com.

Envision Pharma Group Alice Choi Medical Communications Life Sciences Clients Global Technology-enabled Strategic Solutions
PRESS RELEASE

published on 11/15/2023 at 13:00, 2 years 9 months ago

Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
PRESS RELEASE

published on 06/15/2023 at 13:00, 3 years 2 months ago

OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position
PRESS RELEASE

published on 05/09/2023 at 13:00, 3 years 4 months ago

Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors
PRESS RELEASE

published on 05/04/2023 at 13:00, 3 years 4 months ago

Envision Pharma Group Appoints Healthcare Industry Expert and Experienced Leader Dr. Jennifer Costello, PharmD, BCPS, CMPP, as Chief Medical Officer
PRESS RELEASE

published on 05/03/2023 at 15:05, 3 years 4 months ago

Envision Pharma Group Appoints Mike Glover to Senior Vice President, Payer and HTA Solutions to Drive Acceleration and Expansion in Value & Access and Data Analytics
PRESS RELEASE

published on 05/01/2023 at 13:00, 3 years 4 months ago

Envision Pharma Group Appoints Industry Leader Tino Quintero as General Manager/VP of Market Access & Customer Insights
PRESS RELEASE

published on 03/30/2023 at 13:00, 3 years 5 months ago

Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
PRESS RELEASE

published on 03/29/2023 at 17:45, 3 years 5 months ago

Envision Pharma Group Appoints Life Science Industry Expert James Streeter as New President of Technology, CTO

Accesswire

Published on 09/12/2026 at 02:35, 11 hours ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 35 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 30 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 10 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 35 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 6 hours 5 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 20 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 25 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 50 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 20 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 6 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE